Alternating immunochemotherapy of advanced gastric carcinoma: A randomized comparison of carbazilquinone and PSK to carbazilquinone in patients with curative gastric resection Tatsuhei KondoJunichi SakamotoHiroaki Nakazato OriginalPaper Pages: 287 - 295
Clinical effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on various types of neutropenia including cyclic neutropenia Kunitake HirashimaYataro YoshidaSumiya Eto OriginalPaper Pages: 297 - 307
Clinical trial of natural human lymphocyte-derived interleukin 2 in cancer patients: Effects on cytokine production and suppressor cell status Graham PawelecHeinz-Josef LenzGerhard Ehninger OriginalPaper Pages: 309 - 318
Transfer of long-lasting tumor immunity by immune T cells from MHC congenic mice: Migration, survival and tumor-protectivity of cytotoxic donor cells Uwe Zangemeister-WittkeVolker Schirrmacher OriginalPaper Pages: 319 - 329
Antitumor action of an acidic glycoprotein (SAGP) fromStreptococcus pyogenes in mice Junko YoshidaShozo TakamuraShiro Suzuki OriginalPaper Pages: 331 - 336
In vivo effects of human recombinant tumor necrosis factor alone and in combination with other biological response modifiers on human digestive organ cancer xenografts transplanted in nude mice Yoshinori NioTakahiro ShiraishiTakayoshi Tobe OriginalPaper Pages: 337 - 344
Intrapleural application of recombinant interleukin-2 in patients with malignant pleurisy due to lung cancer Kosei YasumotoTakeshi Ogura OriginalPaper Pages: 345 - 349
Growth inhibitory effect of bestatin on choriocarcinoma cell finesin vitro Kazuhiko InoSetsuko GotoYutaka Tomoda OriginalPaper Pages: 351 - 357
The augmentative effect of a protein-bound polysaccharide (PSK) on tumoricidal activity of the soluble factor produced by a streptococcal preparation (OK-432)-activated macrophages Nobutoshi BabaHiroyuki KawamiTetsuya Toge OriginalPaper Pages: 359 - 364
BG-104 enhances the decreased plasma superoxide scavenging activity in patients with Behçet's disease, Sjögren's syndrome or hematological malignancy Laászló PrónaiShigeru Arimori OriginalPaper Pages: 365 - 371
A possible clinical application of multicytokine-producing cytotoxic mononuclear cell (MCCM) therapy Mitsuo KatanoEiro KubotaJutaro Tadano OriginalPaper Pages: 373 - 379